Oncocristin

Oncocristine is a drug from the group of cytostatic drugs of plant origin, which is part of the therapeutic group of alkaloids and derivatives. Manufactured in India by a pharmaceutical company from Tamil Nadu called Tamil Nadu Deffa Pharmaceuticals Ltd. The international name of this drug is Vincristine sulfate. In Russia, the drug was banned for sale in 2014. It is considered a highly effective cytotoxic drug that is used to treat acute lymphoblastic leukemia, lymphomas, and sarcomatosis in various forms. The drug also has a tropic effect against breast cancer sarcomas and sarcomoblastoid cells. Contraindications to taking Oncocristin are intolerance to the drug, hypersensitivity to the drug, the presence